Rachel E. Haurwitz Caribou Biosciences, Inc. (CRBU) insider trading activity

Rachel E. Haurwitz is President and CEO of Caribou Biosciences, Inc.. Currently has a direct ownership of 158,700 shares of CRBU, which is worth approximately $457,056. The most recent transaction as insider was on Feb 20, 2024, when has been sold 118,700 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 159K

0% 3M change

429.0% 12M change

Total Value Held $457,056

Rachel E. Haurwitz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 20 2024	BUY Grant, award, or other acquisition	-	118,700 Added 42.79%	158,700 Common Stock
Jun 08 2023	BUY Exercise of conversion of derivative security	$29,600 $2.96 p/Share	10,000 Added 20.0%	40,000 Common Stock
Mar 20 2023	BUY Exercise of conversion of derivative security	$29,600 $2.96 p/Share	10,000 Added 25.0%	30,000 Common Stock
May 09 2022	BUY Exercise of conversion of derivative security	$29,600 $2.96 p/Share	10,000 Added 33.33%	20,000 Common Stock
Jan 26 2022	BUY Exercise of conversion of derivative security	$29,600 $2.96 p/Share	10,000 Added 0.3%	3,359,395 Common Stock

Also insider at

SEER

Seer, Inc. Healthcare

Director

REH